Precision medicine promises to transform health care. However, low accrual to precision medicine trials and barriers to patient decision-making threaten innovation. Machine learning for matching patients’ genomic information with preclinical datasets and trial eligibility criteria can increase trial accessibility, while conversational AI can provide empathetic, accessible, and tailored information to support patient autonomy for informed…